Belimumab for treating active autoantibody-positive systemic lupus erythematosus

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 10.5 MB)

  Published:

  15 December 2021

• Final appraisal determination committee papers (PDF 2.85 MB)

  Published:

  15 December 2021